NeurAxis, Inc.
General ticker "NRXS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $19.4M (TTM average)
NeurAxis, Inc. follows the US Stock Market performance with the rate: 40.5%.
Estimated limits based on current volatility of 5.9%: low 2.84$, high 3.19$
Factors to consider:
- Total employees count: 19 as of 2023
Short-term NRXS quotes
Long-term NRXS plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 |
|---|---|---|
| Operating Revenue | $2.68MM | $2.46MM |
| Operating Expenses | $6.06MM | $9.12MM |
| Operating Income | $-3.37MM | $-6.66MM |
| Non-Operating Income | $-1.41MM | $-7.96MM |
| Interest Expense | $0.42MM | $5.36MM |
| R&D Expense | $0.23MM | $0.17MM |
| Income(Loss) | $-4.78MM | $-14.63MM |
| Profit(Loss)* | $-4.78MM | $-14.63MM |
| Stockholders Equity | $-5.57MM | $-1.40MM |
| Inventory | $0.05MM | $0.02MM |
| Assets | $1.48MM | $0.51MM |
| Operating Cash Flow | $-2.30MM | $-6.69MM |
| Capital expenditure | $0.06MM | $0.07MM |
| Investing Cash Flow | $-0.06MM | $-0.07MM |
| Financing Cash Flow | $2.29MM | $6.59MM |
| Earnings Per Share** | $-0.57 | $-2.32 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.